SEC 13F Intelligence

Lion Point Capital, LP / HUMA

Lion Point Capital, LP’s Humacyte Inc Position

Does Lion Point Capital, LP own Humacyte Inc (HUMA)? Yes — 650.0K shares worth $394,355 (+2.36% of its 13F portfolio) as of Q1 2026, up from 500.0K shares the prior filed quarter.

Position Value
$394,355
Q1 2026
Shares
650.0K
% of Portfolio
+2.36%
Quarters Held
8
currently held

Position History HUMA

Reported value by quarter
Q3 ’23: $688,550Q3 ’23Q4 ’23: $667,400Q4 ’23Q1 ’24: $730,850Q1 ’24Q1 ’25: $142,368Q1 ’25Q2 ’25: $174,515Q2 ’25Q3 ’25: $145,290Q3 ’25Q4 ’25: $480,250Q4 ’25Q1 ’26: $394,355Q1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026650.0K$394,355+2.36%
Q4 2025500.0K$480,250+2.49%
Q3 202583.5K$145,290+0.83%
Q2 202583.5K$174,515+1.18%
Q1 202583.5K$142,368+0.91%
Q1 2024235.0K$730,850+0.41%
Q4 2023235.0K$667,400+0.33%
Q3 2023235.0K$688,550+0.31%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Lion Point Capital, LP’s full portfolio or all institutional holders of HUMA.